OCA at 13:28, 24 January 2024

OCA — Wed, 24 Jan 2024 13:28:45 GMT

←Older revision		Revision as of 13:28, 24 January 2024
Line 1:		Line 1:

	==Crystal structure of human glutaminyl cyclase in complex with neurotensin 1-5==		==Crystal structure of human glutaminyl cyclase in complex with neurotensin 1-5==
-	<StructureSection load='6yjy' size='340' side='right'caption='[[6yjy]]' scene=''>	+	<StructureSection load='6yjy' size='340' side='right'caption='[[6yjy]], [[Resolution\|resolution]] 1.67Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6YJY OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=6YJY FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6yjy]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6YJY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6YJY FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=6yjy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6yjy OCA], [~~http~~://pdbe.org/6yjy PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6yjy RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6yjy PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6yjy ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.67Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GLN:GLUTAMINE'>GLN</scene>, <scene name='pdbligand=LEU:LEUCINE'>LEU</scene>, <scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene>, <scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=TYR:TYROSINE'>TYR</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6yjy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6yjy OCA], [https://pdbe.org/6yjy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6yjy RCSB], [https://www.ebi.ac.uk/pdbsum/6yjy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6yjy ProSAT]</span></td></tr>
	</table>		</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/QPCT_HUMAN QPCT_HUMAN] Responsible for the biosynthesis of pyroglutamyl peptides. Has a bias against acidic and tryptophan residues adjacent to the N-terminal glutaminyl residue and a lack of importance of chain length after the second residue. Also catalyzes N-terminal pyroglutamate formation. In vitro, catalyzes pyroglutamate formation of N-terminally truncated form of APP amyloid-beta peptides [Glu-3]-beta-amyloid. May be involved in the N-terminal pyroglutamate formation of several amyloid-related plaque-forming peptides.<ref>PMID:15063747</ref> <ref>PMID:18486145</ref> <ref>PMID:21288892</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Amyloidogenic plaques are hallmarks of Alzheimer's disease (AD) and typically consist of high percentages of modified Abeta peptides bearing N-terminally cyclized glutamate residues. The human zinc(II) enzyme glutaminyl cyclase (QC) was shown in vivo to catalyze the cyclization of N-terminal glutamates of Abeta peptides in a pathophysiological side reaction establishing QC as a druggable target for therapeutic treatment of AD. Here, we report crystallographic snapshots of human QC catalysis acting on the neurohormone neurotensin that delineate the stereochemical course of catalysis and suggest that hydrazides could mimic the transition state of peptide cyclization and deamidation. This hypothesis is validated by a sparse-matrix inhibitor screening campaign that identifies hydrazides as the most potent metal-binding group compared to classic Zn binders. The structural basis of hydrazide inhibition is illuminated by X-ray structure analysis of human QC in complex with a hydrazide-bearing peptide inhibitor and reveals a pentacoordinated Zn complex. Our findings inform novel strategies in the design of potent and highly selective QC inhibitors by employing hydrazides as the metal-binding warhead.
		+
		+	Hydrazides Are Potent Transition-State Analogues for Glutaminyl Cyclase Implicated in the Pathogenesis of Alzheimer's Disease.,Kupski O, Funk LM, Sautner V, Seifert F, Worbs B, Ramsbeck D, Meyer F, Diederichsen U, Buchholz M, Schilling S, Demuth HU, Tittmann K Biochemistry. 2020 Jun 29. doi: 10.1021/acs.biochem.0c00337. PMID:32551535<ref>PMID:32551535</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 6yjy" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Glutaminyl cyclase\|Glutaminyl cyclase]]
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Funk LM]]		[[Category: Funk LM]]
	[[Category: Sautner V]]		[[Category: Sautner V]]
	[[Category: Tittmann K]]		[[Category: Tittmann K]]

OCA at 11:40, 29 July 2020

OCA — Wed, 29 Jul 2020 11:40:18 GMT

←Older revision		Revision as of 11:40, 29 July 2020
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6yjy is ~~ON HOLD~~	+	==Crystal structure of human glutaminyl cyclase in complex with neurotensin 1-5==
-		+	<StructureSection load='6yjy' size='340' side='right'caption='[[6yjy]]' scene=''>
-	~~Authors~~:	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6YJY OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6YJY FirstGlance]. <br>
-	~~Description~~:	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6yjy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6yjy OCA], [http://pdbe.org/6yjy PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6yjy RCSB], [http://www.ebi.ac.uk/pdbsum/6yjy PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6yjy ProSAT]</span></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	</table>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Funk LM]]
		+	[[Category: Sautner V]]
		+	[[Category: Tittmann K]]

OCA: Protected "6yjy" [edit=sysop:move=sysop]

OCA — Wed, 15 Apr 2020 05:33:00 GMT

Protected "6yjy" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:33, 15 April 2020

OCA: New page: '''Unreleased structure''' The entry 6yjy is ON HOLD Authors: Description: Category: Unreleased Structures

OCA — Wed, 15 Apr 2020 05:32:59 GMT

New page: '''Unreleased structure''' The entry 6yjy is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 6yjy is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

6yjy - Revision history

OCA at 13:28, 24 January 2024

OCA at 11:40, 29 July 2020

OCA: Protected "6yjy" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 6yjy is ON HOLD Authors: Description: Category: Unreleased Structures